Kyntra Bio (KYNB) EPS (Basic) (QoQ) (2014 - 2026)
Kyntra Bio (KYNB) EPS (Basic) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Kyntra Bio | 29.71 Mn | 29.71 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.91% |
| Dec 31, 2025 | -99.82% |
| Sep 30, 2025 | 3,414.41% |
| Jun 30, 2025 | -71.62% |
| Mar 31, 2025 | -20.40% |
| Dec 31, 2024 | -14.21% |
| Sep 30, 2024 | -1.76% |
| Jun 30, 2024 | 94.14% |
| Mar 31, 2024 | 117.04% |
| Dec 31, 2023 | -45.97% |
| Sep 30, 2023 | 27.51% |
| Jun 30, 2023 | -10.30% |
| Mar 31, 2023 | -15.26% |
| Dec 31, 2022 | 27.67% |
| Sep 30, 2022 | -25.39% |
| Jun 30, 2022 | -14.68% |
| Mar 31, 2022 | 53.09% |
| Dec 31, 2021 | -372.67% |
| Sep 30, 2021 | 136.61% |
| Jun 30, 2021 | -86.94% |